Paratek Pharmaceuticals
PRTK
#9046
Rank
โ‚ฌ0.10 B
Marketcap
1,89ย โ‚ฌ
Share price
0.00%
Change (1 day)
0.24%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -โ‚ฌ41.89 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ0.16 Billion. In 2022 the company made an earning of -โ‚ฌ38.43 Million a decrease over its 2021 earnings that were of -โ‚ฌ34.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ41.89 Million8.99%
2022 -โ‚ฌ38.43 Million10.5%
2021 -โ‚ฌ34.78 Million-46.16%
2020 -โ‚ฌ64.6 Million-31.93%
2019 -โ‚ฌ94.9 Million11.12%
2018 -โ‚ฌ85.4 Million21.19%
2017 -โ‚ฌ70.47 Million-23.22%
2016 -โ‚ฌ91.79 Million54.68%
2015 -โ‚ฌ59.34 Million309.5%
2014 -โ‚ฌ14.5 Million-29.88%
2013 -โ‚ฌ20.67 Million
2011 -โ‚ฌ3.19 Million-59.18%
2010 -โ‚ฌ7.81 Million-53.53%
2009 -โ‚ฌ16.81 Million-161.93%
2008 โ‚ฌ27.12 M-187.43%
2007 -โ‚ฌ31.03 Million11.93%
2006 -โ‚ฌ27.73 Million31.69%
2005 -โ‚ฌ21.05 Million32.4%
2004 -โ‚ฌ15.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.44 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚ฌ52.39 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚ฌ17.49 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA